EUVIMEDOpdag EUVIMED
EUVIMED · CrossrefJournal

iGIE

ISSN 2949-7086 · Elsevier BV

Latest articles

  1. Validation of the immune-mediated colitis endoscopic score using a retrospective cohort of patients with immune-mediated colitis

    Malek Shatila, Carolina Colli Cruz, Krishnavathana Varatharajalu, Andres Caleb Urias Rivera, Kian Abdul-Baki, Kei Takigawa, Tanvi Gupta, Elliot Baerman, Linfeng Lu, Irene Jeong-Ah Lee, Hamza Salim, Raakhi Menon, Andrew Sullivan, Varun Vemulapalli, Cristina Natha, Ayesha Khan, Petros Grivas, David Faleck, Michael Dougan, Anusha Shirwaiker Thomas, Yinghong Wang

    Published: 2026-06DOI: 10.1016/j.igie.2025.09.002

  2. Asia-Pacific consensus on the use of artificial intelligence in colorectal cancer screening and surveillance

    Frederick H. Koh, James W. Li, Sunny H. Wong, Jonathan Lee, Sneha John, Vui Heng Chong, Kai-chun Wu, Rashid Lui, Simon S.M. Ng, Thomas Y.T. Lam, Louis H.S. Lau, Govind K. Makharia, Murdani Abdullah, Hasan Maulahela, Nozomu Kobayashi, Masau Sekiguchi, Jeong-Sik Byeon, Hyun-soo Kim, Yeong Yeh Lee, Han-Mo Chiu, I-Chen Wu, Somchai Leelakusolvong, Prateek Sharma, David Lieberman, Joseph J.Y. Sung

    Published: 2025-12DOI: 10.1016/j.igie.2025.04.001

  3. Endoscopic therapies for walled-off necrosis

    Monica Saumoy, Arvind J. Trindade, Amit Bhatt, Juan Carlos Bucobo, Vinay Chandrasekhara, Andrew P. Copland, Samuel Han, Allon Kahn, Kumar Krishnan, Nikhil A. Kumta, Ryan Law, Jorge V. Obando, Mansour A. Parsi, Guru Trikudanathan, Julie Yang, David R. Lichtenstein

    Published: 2023-06DOI: 10.1016/j.igie.2023.02.001

Volumes

2026 · 1032025 · 1072024 · 1112023 · 942022 · 16

Viden, der passer til dit arbejde.

Fra en gratis start over personlig litteratursøgning til den komplette Research Suite.

Se priser →

Er alle forlagsfuldtekster inkluderet?

Nej. Bibliografiske referencer, abstracts og fuldtekster er forskellige typer indhold. Om en fuldtekst er tilgængelig, afhænger af kilden, Open Access og dine eksisterende licenser. Et EUVIMED-abonnement erstatter ikke yderligere forlagsrettigheder.